Crossmark

Comorbidities and co-medications in populations with and without chronic hepatitis C virus infection in Japan between 2015 and 2016

Crossref DOI link: https://doi.org/10.1186/s12879-018-3148-z

Published Online: 2018-05-24

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ruzicka, Daniel J.

Tetsuka, Jumpei

Fujimoto, Go

Kanto, Tatsuya
Funding

Funding for this research was provided by:

MSD K.K.
License Information

Text and Data Mining valid from 2018-05-24
More Information

Article History

Received: 25 October 2017

Accepted: 15 May 2018

First Online: 24 May 2018

Ethics approval and consent to participate

: This was an observational study using de-identified medical claims data. Because the Japanese Ethical Guidelines for Medical and Health Research Involving Human Subjects () do not apply to studies exclusively using de-identified data, we were not obligated to apply for an ethical approval for this study and to obtain informed consent in this study.

: DJR, JT, and GF are employed by MSD K.K. TK has no competing interests to declare on this work.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.